Becton, Dickinson & Co (NYSE:BDX) on 01/27/2020 declared a dividend of $ 0.7900 per share payable on March 31, 2020 to shareholders of record as of March 10, 2020.
Becton, Dickinson & Co (NYSE:BDX) has paid dividends since 1926, has a current dividend yield of 1.1356693506% and has increased its dividends for 8 successive years.
Becton, Dickinson & Co's market cap is $ 75,255,495,000 and has a PE ratio of 70.62. The stock price closed yesterday at $ 278.25 and has a 52 week low/high of $ 221.47 and $ 280.56.
Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
For more information on Becton, Dickinson & Co click here.
Becton, Dickinson & Co current dividend information as per the date of this press release is:
